It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Visual morphology assessment is routinely used for evaluating of embryo quality and selecting human blastocysts for transfer after in vitro fertilization (IVF). However, the assessment produces different results between embryologists and as a result, the success rate of IVF remains low. To overcome uncertainties in embryo quality, multiple embryos are often implanted resulting in undesired multiple pregnancies and complications. Unlike in other imaging fields, human embryology and IVF have not yet leveraged artificial intelligence (AI) for unbiased, automated embryo assessment. We postulated that an AI approach trained on thousands of embryos can reliably predict embryo quality without human intervention. We implemented an AI approach based on deep neural networks (DNNs) to select highest quality embryos using a large collection of human embryo time-lapse images (about 50,000 images) from a high-volume fertility center in the United States. We developed a framework (STORK) based on Google’s Inception model. STORK predicts blastocyst quality with an AUC of >0.98 and generalizes well to images from other clinics outside the US and outperforms individual embryologists. Using clinical data for 2182 embryos, we created a decision tree to integrate embryo quality and patient age to identify scenarios associated with pregnancy likelihood. Our analysis shows that the chance of pregnancy based on individual embryos varies from 13.8% (age ≥41 and poor-quality) to 66.3% (age <37 and good-quality) depending on automated blastocyst quality assessment and patient age. In conclusion, our AI-driven approach provides a reproducible way to assess embryo quality and uncovers new, potentially personalized strategies to select embryos.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Weill Cornell Medicine of Cornell University, Institute for Computational Biomedicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
2 Yale University, Yale Institute for Network Science, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
3 Weill Cornell Medicine, The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
4 Imperial College, Institute of Reproduction and Developmental Biology, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
5 Emory University School of Medicine, Department of Biomedical Informatics, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
6 Universidad de Valencia, Instituto Valenciano de Infertilidad, Valencia, Spain (GRID:grid.5338.d) (ISNI:0000 0001 2173 938X)
7 Weill Cornell Medicine of Cornell University, Institute for Computational Biomedicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)